$NDAQ

Analysts Are Bullish on Top Financial Stocks: Nasdaq (NDAQ), SLM (SLM)

Analysts cited by TipRanks are bullish on Nasdaq (NDAQ) and SLM (SLM). TD Cowen reiterated Buy ratings, setting $108 for NDAQ (vs $90.42 close) and $32 for SLM (vs $24.18). TipRanks consensus shows Strong Buy on NDAQ with $112.23 target, and Moderate Buy on SLM with $28.14 target. Popular (BPOP) also has a Truist Buy target of $197.

Original reporting
Published Jul 25, 2026, 12:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 25, 2026, 7:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Analysts Are Bullish on Top Financial Stocks: Nasdaq (NDAQ), SLM (SLM) — source image
Decision brief

The 30-second read

$NDAQBullishLow
01

Why it matters

Because the newest disclosed information is limited to analyst rating/target changes, the likely trading impact is sentiment-driven and short-lived unless followed by primary catalysts like earnings, guidance, or regulatory/transaction news.

02

Market read

Useful for gauging near-term sentiment and consensus target direction, but not sufficient for a high-conviction trade without accompanying fundamental updates.

03

What to watch

The article provides no thesis details, valuation assumptions, or risk factors behind the targets, so traders should treat it as sentiment data rather than a fundamental signal.

Relevance 4/10Novelty 4/10Timing: today’s analyst rating and price-target updates cited in the article

Background

The piece summarizes bullish analyst actions (Buy ratings and price targets) for Nasdaq, SLM, and Popular, referencing TipRanks consensus and prior upgrades/initiations.

Company-level read

Ticker impact

$NDAQBullishMedium confidence
Context

TD Cowen maintained a Buy on Nasdaq and set a $108 price target, with TipRanks also citing a $101 upgrade.

Expected impact

Near-term bias upward, but magnitude likely limited to analyst-target repricing rather than a fundamental re-rate.

Evidence & confidence

The article’s actionable content is limited to analyst rating/price-target updates and consensus figures, not earnings, guidance, or regulatory/transaction catalysts.

$SLMBullishMedium confidence
Context

TD Cowen maintained a Buy on SLM and set a $32 price target, while TipRanks cited a prior upgrade to Buy with a $28 target.

Expected impact

Modest upward drift possible if positioning follows upgrades, otherwise limited follow-through.

Evidence & confidence

The newest facts are rating and target changes, which typically move price less than primary disclosures like earnings or guidance.

$BPOPBullishMedium confidence
Context

Truist reiterated a Buy on Popular with a $197 price target, and Benchmark initiated coverage with a $201 target.

Expected impact

Potential short-term support from sentiment/target repricing, with uncertain durability.

Evidence & confidence

The article is essentially a multi-analyst bullish roundup with targets and consensus, not a new fundamental event.

Market effects

Reinforces broadly positive sentiment toward financials, but provides no sector-wide macro datapoint beyond analyst optimism.

None indicated; all cited names are US-listed.

Limited, since the article is a US analyst-target roundup without global policy or cross-border transaction details.

Counterpoint

Analyst-target increases can lag or fail to translate into sustained performance if they are not tied to new earnings, guidance, or measurable catalysts.

Key entities

  • Nasdaq

    Receives a reiterated Buy and a $108 price target from TD Cowen, with an additional cited upgrade to Buy at $101.

  • SLM

    Receives a reiterated Buy and a $32 price target from TD Cowen, with a cited prior upgrade to Buy at $28.

  • Popular

    Receives a reiterated Buy and a $197 price target from Truist, with Benchmark initiating coverage at $201.

Related articles

$NDAQMed

SEC sets Aug. 24 deadline in Nasdaq Bitcoin options review

The SEC ordered a full Commission review of Nasdaq PHLX’s proposed cash-settled Bitcoin index options (QBTC), after CME Group petitioned against a May 22 staff approval. The SEC set Aug. 24 as the deadline for written comments. The May approval remains stayed pending the Commission’s next order, with CFTC and OCC relief still required.

$CMEMed

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction — BigGo Finance

CME Group challenged the SEC’s conditional approval of Nasdaq PHLX’s cash-settled bitcoin index options (ticker QBTC). CME says bitcoin is a commodity, so CFTC has exclusive jurisdiction, and the SEC exceeded its authority. The SEC initiated review and kept a stay. Comments are due Aug. 24. QBTC uses CME CF Bitcoin Real-Time Index and is cash-settled in USD.

$SLMMed

$23 Billion Student-Loan Ruling Shifts Focus to Private Lender Growth

A federal appeals court kept automatic relief in Sweet v. McMahon on track, extending relief to over 450,000 borrowers and more than $23 billion, or about $51,000 per affected borrower. The settlement covers federal debt and leaves private education loans unchanged. The July 1 federal graduate-lending caps may shift funding toward private lenders, with investors watching SLM, SoFi, and Nelnet ahead of Nelnet’s earnings.

$BPOPMed

Banco Popular CEO to retire

Banco Popular of Puerto Rico said CEO Javier Ferrer will retire Aug. 31. Jorge García, previously CFO, will become CEO; Lidio Soriano will move to CFO; and Luis Sousa will become chief risk officer. The changes follow Popular’s Q2 results, with profit up 32.4% and a dividend raised to 90 cents and a $1 billion repurchase authorization.